WASHINGTON, Feb. 17, 2015 (GLOBE NEWSWIRE) -- March is National Colon Cancer Awareness Month, when people around the country work together to shine the spotlight on this common, yet highly preventable disease. To schedule a survivor or expert interview, contact Colleen Pyra at (949) 554-4098.
WHAT: March 6th is National Dress in Blue Day, a time when thousands of individuals, companies and community groups gear up to turn the country blue, the official color for colon cancer awareness. People across the U.S. are hosting denim days at offices and schools, holding local fundraising events, getting involved on social media and so much more. The event takes place in conjunction with National Colon Cancer Awareness Month in March.
WHO: Individuals, schools, companies and community groups across the country. Funds raised on behalf of the Colon Cancer Alliance benefit the organization's financial assistance programs.
WHEN: March 6, 2015
WHERE: Nationwide, in a community near you.
WHY: Colon cancer is the third most commonly diagnosed cancer and the second leading cause of cancer death in men and women combined in the U.S. Nearly 150,000 Americans are diagnosed with this disease every year and 50,000 die from it. But this cancer is largely preventable through recommended screening and is often beatable when detected and treated in its early stages. By wearing blue and urging others to do the same, you can help spread lifesaving information this March by putting colon cancer on the map across the country.
For more information, materials and resources, visit dressinblueday.org. To schedule a survivor or expert interview, contact Colleen Pyra at (949) 554-4098.
The Colon Cancer Alliance's mission is to knock colon cancer out of the top three cancer killers. We are doing this by championing prevention, funding cutting-edge research and providing the highest quality patient support services. Read more information about the Colon Cancer Alliance at ccalliance.org.
A photo accompanying this release is available at: http://www.globenewswire.com/newsroom/prs/?pkgid=30794
